- Home
- ASYS vs CNTB Comparison
ASYS vs CNTB Comparison
Compare ASYS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- CNTB
- Stock Information
- Founded
- ASYS 1981
- CNTB 2012
- Country
- ASYS United States
- CNTB United States
- Employees
- ASYS N/A
- CNTB N/A
- Industry
- ASYS Industrial Machinery/Components
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- CNTB Health Care
- Exchange
- ASYS Nasdaq
- CNTB Nasdaq
- Market Cap
- ASYS 59.4M
- CNTB 44.2M
- IPO Year
- ASYS N/A
- CNTB 2021
- Fundamental
- Price
- ASYS $4.55
- CNTB $0.98
- Analyst Decision
- ASYS
- CNTB Strong Buy
- Analyst Count
- ASYS 0
- CNTB 2
- Target Price
- ASYS N/A
- CNTB $7.50
- AVG Volume (30 Days)
- ASYS 32.7K
- CNTB 92.2K
- Earning Date
- ASYS 08-06-2025
- CNTB 05-15-2025
- Dividend Yield
- ASYS N/A
- CNTB N/A
- EPS Growth
- ASYS N/A
- CNTB N/A
- EPS
- ASYS N/A
- CNTB N/A
- Revenue
- ASYS $90,826,000.00
- CNTB $26,033,000.00
- Revenue This Year
- ASYS N/A
- CNTB N/A
- Revenue Next Year
- ASYS $28.60
- CNTB N/A
- P/E Ratio
- ASYS N/A
- CNTB N/A
- Revenue Growth
- ASYS N/A
- CNTB N/A
- 52 Week Low
- ASYS $3.20
- CNTB $0.51
- 52 Week High
- ASYS $6.96
- CNTB $1.73
- Technical
- Relative Strength Index (RSI)
- ASYS 62.77
- CNTB 59.56
- Support Level
- ASYS $3.93
- CNTB $0.91
- Resistance Level
- ASYS $4.33
- CNTB $1.12
- Average True Range (ATR)
- ASYS 0.23
- CNTB 0.08
- MACD
- ASYS 0.02
- CNTB 0.01
- Stochastic Oscillator
- ASYS 100.00
- CNTB 59.26
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.